Xeris Biopharma Holdings Inc (NAS:XERS)
$ 3.11 0.09 (2.98%) Market Cap: 463.39 Mil Enterprise Value: 642.21 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 75/100

Q2 2024 Xeris Biopharma Holdings Inc Earnings Call Transcript

Aug 08, 2024 / 12:30PM GMT
Release Date Price: $2.23 (+4.69%)
Operator

Hello, everyone, and Welcome to today's Xeris Biopharma second-quarter 2024 financial results call. My name is Drew, and I'll be your operator today. (Operator Instructions) I will now turn the call over to Allison Wey, Senior Vice President of Investor Relations and Corporate Communications to begin. Please go ahead.

Allison Wey
Xeris Biopharma Holdings Inc - Senior Vice President Investor Relations & Corporate Communications

Thank you, Drew. Good morning, and welcome to Xeris's Biopharma second quarter and first half 2024 financial results conference call and webcast. This morning, we issued our press release, which can be found on our website. We're joined this morning by John Shannon, our new CEO; and Steve Piper, our CFO. After our prepared remarks, we will open the lines for questions.

Before we begin, I would like to remind you that this call will contain forward-looking statements concerning the company's future expectations, plans, prospects, and financial performance. Forward-looking statements are subject to risks and uncertainties that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot